NASDAQ: ADRX
Adarx Pharmaceuticals Inc Earnings Dates, Reports, Calls

Adarx Pharmaceuticals earnings were N/A for the trailing 12 months ending Jun 30, 2026, with N/A growth year over year. The latest ADRX earnings report on Jun 30, 2026 announced Q2 2026 earnings of N/A, down N/A from last quarter. For the last reported fiscal year 2025 ending Dec 31, 2025, ADRX reported annual earnings of -$73.1M, with 57.7% growth.

ADRX earnings history

Current Revenue
$0.0
Current Earnings
$0.0
Current Profit Margin
0%

ADRX Return on Equity

Insufficient data to display

ADRX Return on Assets

Insufficient data to display

Be the first to know when ADRX announces earnings.

ADRX Return on Capital Employed

Current Company
0%
Current Industry
-7.4%

ADRX vs Biotech Stocks

TickerEBITDAEarningsY/Y EarningsEPS
ABVC-$6.46M-$7.11MN/A-$0.29
ABVX-$285.22M-$460.11MN/A-$5.96
ACET-$89.96M-$98.97MN/A-$10.46
ADRXN/AN/AN/AN/A
AARD-$69.51M-$69.89MN/A-$3.21

Adarx Pharmaceuticals Earnings Reports & History FAQ

What was ADRX's earnings growth in the past year?

As of Adarx Pharmaceuticals's earnings date in Q3 2026, Adarx Pharmaceuticals's earnings has grown year over year. ADRX earnings in the past year totalled N/A.

If you're new to stock investing, here's how to buy Adarx Pharmaceuticals stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.